Mizuho Markets Americas’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Mizuho Markets Americas’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-255,749	Closed	-$17.4M	–	156
2022 Q3	$17.4M	Buy	255,749 +67,468	+36%	+$3.72M	0.76%	21
2022 Q2	$6.02M	Sell	188,281 -78,233	-29%	-$2.29M	0.44%	43
2022 Q1	$9.23M	Buy	+266,514	New	+$7.97M	0.56%	23

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mizuho Markets Americas's GBT Position: Q4 2022 in Review

Mizuho Markets Americas sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 255,749 shares — an estimated $17.4M sold.

Mizuho Markets Americas first reported a position in GBT in Q1 2022 and held it in 3 quarters. The position peaked at $17.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Mizuho Markets Americas reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Mizuho Markets Americas sold 255,749 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $17.4M.
Mizuho Markets Americas first reported a position in Global Blood Therapeutics, Inc. in Q1 2022 and held it in 3 quarters.
Mizuho Markets Americas's Global Blood Therapeutics, Inc. position peaked at $17.4M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Mizuho Markets Americas's 13F filing for Q4 2022, filed 3 Feb 2023.